Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Lung Cancer

  Free Subscription


Articles published in Am J Pathol

Retrieve available abstracts of 9 articles:
HTML format



Single Articles


    October 2022
  1. ZHAI WY, Duan FF, Wang YZ, Wang JY, et al
    Integrative Analysis of Bioinformatics and Machine Learning Algorithms Identifies a Novel Diagnostic Model Based on Costimulatory Molecule for Predicting Immune Microenvironment Status in Lung Adenocarcinoma.
    Am J Pathol. 2022;192:1433-1447.
    PubMed     Abstract available


    August 2022
  2. KANTARCI A, Kansal S, Hasturk H, Stephens D, et al
    Resolvin E1 Reduces Tumor Growth in a Xenograft Model of Lung Cancer.
    Am J Pathol. 2022 Aug 6. pii: S0002-9440(22)00215.
    PubMed     Abstract available


    June 2022
  3. MASAWA M, Sato-Yazawa H, Kashiwagi K, Ishii J, et al
    REST Inactivation and Coexpression of ASCL1 and POU3F4 Are Necessary for the Complete Transformation of RB1/TP53-Inactivated Lung Adenocarcinoma into Neuroendocrine Carcinoma.
    Am J Pathol. 2022;192:847-861.
    PubMed     Abstract available


  4. ZHOU Y, Chang M, Wang N, Zhuang Y, et al
    Phosphatidylserine-Specific Phospholipase A1 Limits Aggressiveness of Lung Adenocarcinoma by Lysophosphatidylserine and Protein Kinase A-Dependent Pathway.
    Am J Pathol. 2022;192:970-983.
    PubMed     Abstract available


    April 2022
  5. PARK J, Cho HG, Park J, Lee G, et al
    Artificial Intelligence-Powered Hematoxylin and Eosin Analyzer Reveals Distinct Immunologic and Mutational Profiles among Immune Phenotypes in Non-Small-Cell Lung Cancer.
    Am J Pathol. 2022;192:701-711.
    PubMed     Abstract available


    December 2021
  6. DEHKHARGHANIAN T, Rahnamayan S, Riasatian A, Bidgoli AA, et al
    Selection, Visualization, and Interpretation of Deep Features in Lung Adenocarcinoma and Squamous Cell Carcinoma.
    Am J Pathol. 2021;191:2172-2183.
    PubMed     Abstract available


    November 2021
  7. KHADIRNAIKAR S, Chatterjee A, Shukla S
    Identification and Characterization of Senescence Phenotype in Lung Adenocarcinoma with High Drug Sensitivity.
    Am J Pathol. 2021;191:1966-1973.
    PubMed     Abstract available


    September 2021
  8. WANG Y, Yan F, Nasar A, Chen ZS, et al
    CUL4(high) Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival.
    Am J Pathol. 2021;191:1638-1650.
    PubMed     Abstract available


    July 2021
  9. GOERTZEN N, Pappesch R, Fassunke J, Bruning T, et al
    Quantum Cascade Laser-Based Infrared Imaging as a Label-Free and Automated Approach to Determine Mutations in Lung Adenocarcinoma.
    Am J Pathol. 2021;191:1269-1280.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: